WHO ICTRP trial
Oxaliplatin, Leucovorin Calcium, and Fluorouracil With or Without Bevacizumab in…
PER-060-06 · Registro Peruano de Ensayos Clínicos (REPEC) · Not Recruiting
Key facts
| Trial ID | PER-060-06 |
|---|---|
| Public title | Oxaliplatin, Leucovorin Calcium, and Fluorouracil With or Without Bevacizumab in Treating Patients Who Have Undergone Surgery for Stage II Colon Cancer |
| Scientific title | PHASE III, RANDOMIZED, STUDY, THAT COMPARES 5-FU, LEUCOVORIN AND OXALIPLATIN AND BEVACIZUMAB IN PATIENTS WITH STADIUM II OF CANCER OF COLON WITH HIGH RISK OF RECURRENCE FOR THE PROGNOSTIC VALUE OF MOLECULAR MARKERS DETERMINED PROSPECTIVELY |
| Primary sponsor | EASTERN COOPERATIVE ONCOLOGY GROUP (ECOG), |
| Registry | Registro Peruano de Ensayos Clínicos (REPEC) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | III |
| Countries | Ireland;United Kindgdom;South Africa;Canada;Peru;United States |
| Conditions | -C189 Colon, unspecified Colon, unspecified;C189;Colon, unspecified |
| Interventions | Group name:ARM A Type of group;2 N° of participants:722 Intervention(s) description:This group will be treated with: Oxaliplatin at a dose of 85 mg / m2 in IV infusion of 2 hours + Leucovorin at a dose of 400 mg / m2 in IV infusion of 2… |
| Registration date | Jan 18, 2007 |
| Target size | 500 |
| Secondary IDs | NA;NCT00217737;2007-001195-36 |
| Registry page | ins.gob.pe |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: